| (Values in U.S. Thousands) | Sep, 2023 | Sep, 2022 | Sep, 2021 | Sep, 2020 | Sep, 2019 |
| Sales | 0 | 0 | 0 | 0 | 1,610 |
| Sales Growth | unch | unch | unch | -100.00% | +140.30% |
| Net Income | -4,720 | -1,720 | -2,510 | -6,770 | 2,340 |
| Net Income Growth | -174.42% | +31.47% | +62.92% | -389.32% | +158.94% |
Novaccess Global Inc (XSNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
NovAccess Global Inc. is a biomedical company developing novel immunotherapies for brain tumor patients. NovAccess Global Inc. is based in CLEVELAND, OH.
Fiscal Year End Date: 09/30